Last Updated on December 24, 2023 by The Health Master
Mumbai: Lupin Limited has announced that its alliance partner Caplin Steriles Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Rocuronium Bromide Injection, 10 mg/mL in 5 mL and 10 mL multi-dose vials.
The injections are the generic version of Zemuron Bromide Injection of Organon USA Inc and will be used as an adjunct to general anaesthesia.
As per the IQVIA MAT December 2022, Rocuronium Bromide Injection had an annual sale of approximately $53 million in the US.
USFDA gives approval for Prochlorperazine Maleate Tablets USP
USFDA gives approval for Ranolazine ER tablets
USFDA gives nod for Human Trial of drug for the treatment of advanced cancer
USFDA gives approval for Clindamycin Hydrochloride Capsules
USFDA gives nod for generic version of Famotidine tablets
USFDA gives approval for Lenalidomide capsules
Difference: Disintegration and Dissolution test in pharma industry
USFDA gives approval for Prochlorperazine Maleate Tablets USP
New study on the effectiveness of Homoeopathy Medicines
PCI to extend approval for existing Pharmacy Courses
No link between antacid Ranitidine and cancer risk: Study
How to prepare SOPs in the Pharma Industry
NMC rejects proposal to allow Pharmacists to write Prescriptions
SC: Doctor can’t be punished under D&C Act for storing small quantities of medicines
Difference between branded and generic medicines
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
